We have shown previously that preconditioning myocardium with four 5-minute episodes of ischemia and reperfusion dramatically limited the size of infarcts caused by a subsequent 40-minute episode of sustained ischemia. The current study was undertaken to assess whether the same preconditioning protocol slowed the loss of high energy phosphates, limited catabolite accumulation, and/or delayed ultrastructural damage during a sustained ischemic episode. Myocardial metabolites and ultrastructure in the severely ischemic subendocardial regions were compared between control and preconditioned canine hearts. Hearts (four to 10 per group) were excised after 0, 5, 10, 20, or 40 minutes of sustained ischemia. All groups had comparable collateral blood flow. Preconditioned hearts developed ultrastructural injury more slowly than controls; evidence of irreversible injury was observed after 20 minutes in controls but not until 40 minutes in preconditioned hearts. Furthermore, after 40 minutes of ischemia, irreversible injury was homogeneous in controls but only focal in preconditioned myocardium. Preconditioning reduced starting levels of ATP by 29%. Nevertheless, it also slowed the rate of ATP depletion during the episode of sustained ischemia, so that after 10 minutes of ischemia, preconditioned hearts had more ATP than controls. However, after 40 minutes, ATP contents were not significantly different between groups. Preservation ofATP resulted from reduced ATP utilization and was not due to increased ATP production. Accumulation of purine nucleosides and bases (products of adenine nucleotide degradation) was limited in preconditioned myocardium. Accumulation of glucose-i-phosphate, glucose-6-phosphate, and lactate also was reduced markedly by preconditioning, due to reduced rates of glycogen breakdown and anaerobic glycolysis. We propose that preconditioning reduces myocardial energy demand during ischemia, which results in a reduced rate of high energy phosphate utilization and a reduced rate of anaerobic glycolysis. Either preservation of ATP or reduction of the cellular load of catabolites may be responsible for delaying ischemic cell death. (Circulation Research 1990;66:913-931) 
T he biochemical mechanism through which cardiac myocytes become irreversibly injured during ischemia has been the subject of intensive investigation. Most of the alterations observed in acute ischemia may be attributed either to the loss of critical metabolites such as ATP or to the accumulation of a myriad of potentially harmful catabolites. The most popular hypotheses regarding the cause of ischemic cell death focus on these two processes, but the actual mechanism of lethal injury
is not yet known.
In an attempt to separate the effects of catabolite accumulation from those of ATP depletion, we have examined the effects of repeated coronary occlusions. We hypothesized that repeated coronary occlusions might cause partial depletion of ATP, whereas intermittent reperfusion would wash out ischemic catabolites. In a recent study,' we proposed that multiple brief ischemic episodes actually might protect the heart from a subsequent sustained ischemic insult. To test this hypothesis, dogs were "preconditioned" with four 5-minute episodes of ischemia, each separated by 5 minutes of reperfusion, and then subjected immediately to a sustained occlusion of either 40 minutes or 3 hours. Control animals received either a single 40-minute or 3-hour occlusion. In the 40minute study, infarcts in preconditioned hearts were smaller than controls at any level of collateral flow, averaging 25% of control infarct size. In the 3-hour study, preconditioning had no effect on infarct size. 914 Circulation Research Vol 66, No 4, April 1990 The present study was performed to investigate the metabolic and ultrastructural basis for the protective effect seen in the 40-minute study. Three experimental questions were addressed: 1) Does preconditioning preserve the ATP content of severely ischemic myocardium? 2) Does preconditioning limit the accumulation of ischemic catabolites? 3) Does preconditioning alter the ultrastructural manifestations of ischemic injury?
Materials and Methods Animal Selection and Surgical Preparation
All experiments reported here conformed to the American Physiological Society's guidelines regarding the use of laboratory animals. Healthy adult mongrel dogs of either sex, weighing between 10 and 25 kg and having hematocrits of 35 or more, were used. The preparation used in this study has been described in detail previously.2 In brief, dogs were anesthetized with 30-40 mg/kg sodium pentobarbital and mechanically ventilated. Saline-filled catheters were placed in the right femoral artery and vein. Arterial blood gases were monitored to ensure appropriate ventilation. A left thoracotomy was performed in the fourth intercostal space, and the heart was suspended in a pericardial cradle. The left circumflex coronary artery was isolated between the atrial appendage branch and the first large marginal branch, and a piece of umbilical tape was passed around it. Catheters were placed in the left atrium for measurement of pressure and injection of microspheres. Tween 80 (0.6 ml of a 0.05% solution) was administered to desensitize animals before injection of microsphere suspensions containing this detergent. Left atrial pressure, arterial pressure, lead II of the electrocardiogram, and pericardial temperature were monitored on a Gould Brush 2400 recorder (Gould, Cleveland, Ohio). Dogs were allowed at least 15 minutes after surgical preparation to reach steady state. Measurement of Regional Blood Flow Regional myocardial blood flow was measured by use of 10±2-,um radioactive microspheres (New England Nuclear, Boston, Massachusetts). At the times listed in the experimental design section, 2-3 million microspheres labeled with 46Sc, 85Sr, 1l3Sn, M1Ce, or M53Gd (two to three isotopes per animal) were injected through the catheter in the left atrial appendage, followed by a 15-ml saline flush. Beginning just before and continuing 2.5 minutes after injection, reference blood samples were withdrawn from the femoral artery at a rate of 7.75 ml/min. Microsphere radioactivity was measured in a gamma counter (model A5912, Packard Instrument, Downers Grove, Illinois) with correction for overlap of isotopic spectra. Myocardial blood flow (expressed as milliliters per minute per gram wet weight) was calculated according to the formula: tissue flow=(tissue counts) (reference blood flow)/reference blood counts.
PRECONDITIONED GROUPS 01 RI 02 R2 03 R3 04 R4 -40 0 5 10 20 Minutes CONTROL GROUPS 0 5 10 20 40 Minutes FIGURE 1. Diagram of experimental design. Preconditioned animals received four 5-minute circumflex coronary occlusions, each separated by 5 minutes of reperfusion. Hearts were excised after 0, 5, 10, 20, or 40 minutes of ischemia (arrows). Control hearts were excised after single occlusions of5, 10, 20, or 40 minutes duration. 0, occlusion; R, reperfusion.
Experimental Design
The experimental design is shown in Figure 1 . Nine groups of dogs were used to assess the effect of preconditioning on myocardial metabolism. Preconditioned dogs received four 5-minute circumflex occlusions, each separated by 5 minutes of reperfusion. Hearts then were excised after 0, 5, 10, 20, or 40 minutes of sustained ischemia. Control hearts were excised after 5, 10, 20, or 40 minutes of sustained ischemia. Some of the control animals were obtained from a previously completed study.2 These included four of six dogs from the 5-minute group, all six dogs from the 10-minute group, and six of 10 dogs from the 40-minute group. These animals were treated in a manner identical to other controls, with the exception of the time of microsphere injection in the 40-minute dogs. Myocardial blood flow was measured before occlusion in every animal. In most preconditioned groups, collateral flow was measured midway through the first occlusion and again midway through the final occlusion. However, in the preconditioned 5-minute group, the final microsphere injection was done midway through the penultimate occlusion, to ensure that flow measurements would be completed by the time of cardiac excision. In all control animals, collateral flow was measured midway through the occlusion. In all current controls, blood flow also was measured 2.5 minutes into the sustained occlusion.
Tissue Sampling for Blood Flow and Metabolic Analyses
At the appropriate time, the ventricles were excised quickly by cutting across the atrioventricular groove with a sharp knife and then were plunged into 750 ml ice-cold isotonic KCI, in which the mixture was swirled to facilitate heat exchange. After cooling for 1 minute, the left ventricular cavity was opened, and transmural slabs were cut from the ischemic and nonischemic regions, including the posterior and anterior papillary muscles, respectively, and the regions immediately basal to them. These slabs were quick-frozen in Freon cooled with liquid nitrogen 40 and freeze-dried in a lyophilizer. This rapid excision technique allows accurate determination of ATP and lactate, but not creatine phosphate (CP).3 Delineation of the ischemic vascular bed was accomplished by intravenous injection of the fluorescent dye thioflavin S (1 mllkg of a freshly centrifuged 4% solution), 15 seconds before excision. In studies ending in reperfusion, the artery was reoccluded 15 seconds before excision to permit the use of thioflavin S. After quick-freezing the transmural samples, tissue was cut from the ischemic posterior and nonischemic anterior papillary muscles for electron microscopic evaluation (see below). The remainder of the left ventricle was examined under ultraviolet light, where the nonischemic regions fluoresced. A map corresponding to thioflavin S fluorescence was drawn and was later used to ensure that samples for metabolic analysis did not contain admixtures of ischemic and nonischemic myocardium. The remainder of the left ventricle was fixed in formalin.
The freeze-dried slabs were divided at the juncture of the papillary muscle and the basal region above it. Each of these transmural blocks was trimmed of epicardium and endocardium, as well as any apparent blood vessels, and subdivided into subendocardial, midmyocardial, and subepicardial thirds for metabolic and blood flow analyses. Corresponding samples were also obtained from the formalin-fixed ventricle for blood flow measurements. The flows in the freeze-dried samples were used to verify that samples were not contaminated by nonischemic tissue and were representative of the flows measured in the larger samples. Because the tissue samples obtained from the formalin-fixed ventricle were generally larger, we considered them to provide more accurate measures of flow to the ischemic vascular bed. There was good agreement between the two types of samples, and for the sake of brevity, we have reported only the flow from the formalin-fixed tissue. In no case was a sample used if the measured flow in the dry tissue differed markedly from that measured in formalin-fixed tissue. Metabolic and blood flow data from the subendocardial regions form the basis of this report. The rationale for confining the present report to subendocardial samples is that this region contains the myocytes that undergo irreversible injury during a 40-minute episode of ischemia; correspondingly, it was in this region that necrosis was prevented by preconditioning.1 Thus, metabolic effects of preconditioning that are responsible for cellular protection should occur in the subendocardium.
Metabolic Analyses
After measurement of microsphere radioactivity, the tissue samples again were dried and weighed. In the early phase of this study, small "subsamples" weighing 30-50 mg were cut from the larger tissue pieces in which blood flow was measured. These then were homogenized in 3.6% ice-cold perchloric acid with a Tri-R homogenizer (Tri-R Instrument, Jamaica, New York). Approximately midway through the study, the sampling procedure was modified to improve precision. Rather than obtaining subsamples from the larger tissue specimens in which blood flow was measured, the entire piece of dried myocardium was ground to a fine powder with a mortar and pestle. Blood vessels and connective tissue that would not pulverize were removed. The resultant powder was mixed thoroughly, and 30-50 mg was homogenized in perchloric acid as described above. After homogenization, analysis proceeded in an identical fashion. This improvement avoided potential errors inherent in sampling from regions of myocardium that may be of heterogeneous composition. Removal of connective tissue and blood vessels reduced the dry weight of the myocardium slightly; this procedure concentrated tissue metabolites by approximately 5% (based on differences in ATP contents of nonischemic myocardium). We believe this small systematic difference between methods is acceptable and have pooled the data obtained by the two techniques.
After homogenization, the slurries were centrifuged, and the supernatants were neutralized with K2C03 and KOH to pH 5.0-6.0 and then frozen. The extracts were later centrifuged to remove the KCl04 and assayed by both enzymatic methods and highperformance liquid chromatography (HPLC). ATP, ADP, AMP, adenosine, inosine, hypoxanthine, and xanthine were measured by HPLC using a modification of the method of Anderson and Murphy,4 as described previously.2 Glucose-6-phosphate (G-6-P) and lactate were measured enzymatically as described previously.5 Glycogen was determined by a modification of the technique of Keppler and Decker.6 Glucose, glucose-i-phosphate (G-1-P), and a-glycerophosphate (a-GP) were measured in the neutral perchloric acid extract by the techniques of Bergmeyer et al,7 Bergmeyer and Michal, 8 and Michal and Lang, 9 respectively . Enzymatic assays were usually done in duplicate; HPLC assays were generally done singly. Metabolite content is expressed in micromoles per gram dry weight.
Utilization of High Energy Phosphates
The rate of high energy phosphate (HEP) utilization in severely ischemic myocardium can be estimated according to the equation10: HEP utilization=HEP production+HEP depletion In tissue receiving virtually no flow, the principal source of new HEP is anaerobic glycolysis. If one assumes that all G-6-P that enters glycolysis comes from endogenous glycogen, then HEP production can be estimated as: HEP production= 1.SAlactate HEP depletion is calculated from changes (A) in tissue ATP, ADP, and CP: HEP depletion=2AATP+AADP+ACP 10 7 Preconditioned groups 0 6 0 ... 6 (100%) HEP production may be overestimated slightly if exogenous glucose is converted to lactate (which yields only one HEP bond per lactate molecule produced) or underestimated if lactate is washed out or if pyruvate is transaminated to alanine, rather than reduced to lactate. Despite these caveats, the equation does provide a useful estimate of HEP utilization in tissue receiving very little or no flow.
Electron Microscopy
Our previous study quantitatively analyzed the extent of ischemic injury in the two groups at the light microscopic level. Therefore, the electron microscopic evaluation was designed to analyze qualitatively the nature of ultrastructural changes in ischemic preconditioned and control myocardium. Immediately after obtaining tissue samples for metabolic analysis, thin slices of myocardium were obtained from the nonischemic anterior papillary muscle and the ischemic posterior papillary muscle. The ischemic samples were taken from two regions, 0.25-0.5 cm apart, to improve the likelihood of detecting focal injury. Multiple cubes, 1 mm in dimension or smaller, were cut with a razor blade under glutaraldehyde and were transferred to vials containing 4% glutaraldehyde in 0.1 M cacodylate buffer. The tissue was fixed for at least 4 hours and then postosmicated in 1% osmium tetroxide in 0.1 M collidine buffer. After osmium fixation, the tissue was dehydrated in a graded ethanol series, rinsed in propylene oxide, and embedded in Poly/ Bed 812 (Polysciences Inc, Warrington, Pennsylvania). Semithin sections were cut from at least two blocks from the nonischemic region and from four to eight blocks from the ischemic region, stained with toluidine blue, and examined by light microscopy. Longitudinally oriented, artifact-free areas were selected from blocks that were representative of the ischemic and nonischemic samples. Ultrathin sections were cut from these regions with a diamond knife, mounted on copper grids, and stained with lead citrate and uranyl acetate. Samples were examined with an electron microscope (model JEM 100B, JEOL U.S.A., Peabody, Massachusetts), and representative areas were photographed.
Statistical Analysis
Metabolic and blood flow data from the papillary muscle and the basal sample above it were averaged to obtain subendocardial means. Nonischemic metabolite levels were not significantly different among the nine groups and have been pooled to form the control 0-minute group. Dogs with mean subendocardial flow greater than 0.15 ml/min* g were excluded from group comparison, because they exhibited only mild subendocardial ischemia. Calculations of HEP utilization and glycogen utilization, as well as data presented in all figures, are based on further subgroupings of dogs that had the most severe ischemia (generally subendocardial flow c0.07 ml/min* g, unless otherwise noted). This was done for two reasons: 1) Calculation of metabolic fluxes such as HEP and glycogen utilization are accurate only to the extent that individual metabolites are not washed out by collateral blood flow. 2) Elimination of animals with less severe ischemia permits more accurate calculation of these parameters. Additionally, it was in this severely ischemic subgroup of animals that infarct size limitation was most dramatic,1 and hence, the metabolic differences were expected to be most pronounced. Data are expressed as group mean-+±SEM. To test for differences when three or more groups were compared, a one-way analysis of variance was used. When comparing two groups of dogs, Student's two-tailed unpaired t test was used. When comparing data within the same animals, the corresponding paired t test was used. A value of pO0.05 was considered indicative of a statistically significant difference.
Results

Mortality, Exclusions, and Collateral Blood Flow
The number of animals in each group, premature mortality due to ventricular fibrillation, and group Table 1 . Survival ranged from 78-100% in the nine groups. Eight of 61 surviving dogs had subendocardial collateral flows greater than 0.15 ml/min * g and have been excluded from this report. Table 2 gives mean metabolic levels found in the nine groups.
Collateral blood flow data are given in Table 3 . There were no significant differences among groups in collateral flow when dogs with subendocardial flows greater than 0.15 ml/min * g were excluded. In all remaining dogs, collateral flow was less than 5% of preocclusion flow. In both preconditioned and control groups, there was a trend for collateral flow to increase from the first to the second measurement, which was more evident when high-flow dogs were included. We have shown previously that blood flow changes in control hearts over time were similar to changes in flow between occlusions in preconditioned hearts.1 Thus, it is unlikely that preconditioning increases collateral flow. We believe the differences between early and late flow measurements resulted from dilation of collateral vessels, which is complete between 2.5 and 5 minutes of ischemia. Collateral flow to the less severely ischemic midmyocardium and subepicardium exhibited more substantial increases in flow from first to second measurements in both control and preconditioned hearts (data not shown).
Myocardial Ultrastructure
The ultrastructure of normal myocardium from the anterior papillary muscle is shown in Figure 2 . Nonischemic myocytes were characterized by finely dispersed nuclear chromatin, abundant glycogen granules in the sarcoplasm, and slightly contracted myofibrils. Mitochondria had electron dense matrices and tightly packed cristae. The sarcolemma was attached to the underlying myofibrils at each Z disk, giving it a scalloped appearance; the basal lamina always was in close apposition to the sarcolemma. Capillary endothelial cells exhibited an abundance of pinocytotic vesicles, and their nuclear chromatin was finely dispersed.
The ultrastructural changes that occurred during ischemia in control myocardium were similar to those described previously.5,11 After 5 minutes of ischemia, mild ultrastructural alterations consisting of slight myofibrillar stretching and modest swelling in some mitochondria were observed. After 10 minutes of ischemia, these changes were more pronounced and, in addition, included moderate clumping and peripheral aggregation of nuclear chromatin. Mitochondrial swelling was more evident, with occasional mitochondria showing severe swelling and disorganization of cristae. Mitochondria and myofibrils were more loosely packed, indicative of cell swelling. The edema, coupled with glycogen depletion, resulted in clearing of the sarcoplasm.
After 20 minutes of ischemia ( Figure 3 ), control hearts exhibited signs of homogeneous severe injury. subendocardial collateral flows <0.15 mI/min g. In dogs having two collateral flow measurements, the second flow value is reported. There were no significant differences between any of the groups. sarcoplasmic swelling, and myofibrillar stretching were much more pronounced than in the 10-minute group. Virtually all mitochondria were swollen; matrices were electron lucent, and cristae frequently were in disarray. Some mitochondria contained amorphous matrix densities, indicating that injury was entering the irreversible phase. However, amorphous matrix densities were not present in all hearts and were not present in all subendocardial myocytes within a given heart. The sarcolemmal attachments at the Z disks were intact, and no sarcolemmal breaks were detected.
After 40 minutes of severe ischemia (Figure 4 ), there was widespread evidence of irreversible injury. Virtually all mitochondria contained amorphous matrix densities. The sarcolemma exhibited severe damage, including separation from its attachments at the Z disks and focal discontinuities in the plasma membrane; the basal lamina appeared to be intact. Most endothelial cell nuclei exhibited margination and clumping of chromatin; however, pinocytotic vesicles remained abundant in the endothelial cytoplasm.
:~~~~W FIGURE 2. Transmission electron micrograph of nonischemic myocardium from the anterior papillawy muscle. This figure illustrates characteristics typical of nonischemic muscle, including slightly contracted myofibrils (ME), a nucleus (Nu) with finely dispersed chromatin, abundant granular glycogen in the sarcoplasm, and mitochondria (M) with tightly packed cristae and electron-dense matrices. The sarcolemma is attached to the underlying myofibrils at the Z disks (arrows). In Glycogen is nearly absent. Most mitochondnra are swollen and exhibit disorganization of cristae. Several mitochondria contain amorphous matrix densities (AMD), signs of irreversible ischemic injury. The sarcolemma (arrows) appears structurally intact. In the upper left is a capillary endothelial cell, also showing marked clumping and margination of nuclear chromatin; endocytotic vesicles are still present in the cytoplasm. Collateral blood flow in this heart was 0.07 ml/min * g. The bar denotes 1 pm. Original magnification, x 7,300.
Myocardium sampled at the end of preconditioning (i.e., at the end of the fourth 5-minute reperfusion) was indistinguishable from nonischemic control myocardium ( Figure 5 ). Chromatin was finely dispersed. Myofibrils were slightly contracted, and glycogen was present in the sarcoplasm. Mitochondria exhibited tightly packed cristae and electron-dense matrices. Five minutes of ischemia in the preconditioned hearts induced little ultrastructural change. Myofibrils were slightly relaxed with narrow I bands, and occasional mitochondria exhibited mild swelling. After 10 minutes of sustained ischemia, ultrastructural injury was still relatively mild in most preconditioned hearts. Chromatin was distributed evenly, and there was little evidence of sarcoplasmic or mitochondrial swelling. Myofibrils were mildly stretched; glycogen was generally present. An occasional myocyte exhibited more severe glycogen depletion, myofibrillar stretching, and mitochondrial swelling, but this severity was infrequent. However, one dog from this group exhibited more severe chromatin clumping, myofibrillar stretch, and mitochondrial and sarcoplasmic swelling in all myocytes. Collateral flow in this dog was 0.00 ml/ming.
After 20 minutes of sustained ischemia, injury in preconditioned hearts was heterogeneous. Some regions ( Figure 6 , top panel) were indistinguishable from the 10-minute preconditioned myocardium, showing mild myofibrillar stretch, mild clumping of chromatin, and slight swelling of mitochondria and the sarcoplasm. These modest alterations were seen uniformly in dogs with less severe ischemia and were common even in dogs with severe ischemia. However, severely ischemic myocardium also exhibited regions with severe reversible injury ( Figure 6 , bottom panel), characterized by marked mitochondrial and sarcoplasmic swelling, stretching of myofibrils, and virtual absence of glycogen. Of note, unlike the 20-minute control group, no amorphous matrix densities were and contain numerous amorphous matrix densities (AMD), signs of irreversible ischemic injury. The sarcoplasm appears clear, due to edema and glycogen depletion. Golgi apparatus (GA) is present, as well as primary and secondary lysosomes; these structures appear indistinguishable from nonischemic tissue. Collateral blood flow in this heart was 0.06 ml/min g. The bar denotes 1 prm. Original magnification, x 12,250. seen in any mitochondria, and chromatin clumping and margination were never as severe.
The 40-minute preconditioned hearts also exhibited heterogeneous injury. Hearts with less severe ischemia typically showed characteristics of reversible injury as described for the 10-and 20-minute preconditioned groups; the mitochondria of occasional cells contained amorphous matrix densities, indicating irreversible ischemic injury. In hearts with the most severe ischemia, there still were many regions exhibiting moderate to severe reversible injury (Figure 7, top panel) . However, areas exhibiting mitochondrial amorphous matrix densities were more frequently seen in this severely ischemic tissue; occasional cells displayed severe membrane damage, characterized by the appearance of subsarcolemmal blebs and focal discontinuities in the plasma membrane (Figure 7 , bottom panel). However, even in these severely ischemic hearts. irreversible injury was not as uniform as that seen in the 40-minute control hearts.
Adenine Nucleotides
The time course of ATP depletion is shown in Figure 8 . In control animals, ATP was degraded rapidly during the first 10 minutes of ischemia, from a nonischemic level of 24.6±+-0.3 to 9.1±+ 0.8 gmol/g dry wt. ATP depletion slowed thereafter, reaching a level of 2.8+0.7 gmol/g dry wt after 40 minutes of continuous ischemia. The four 5-minute occlusions and reperfusions of the preconditioning process reduced ATP content by 29%, to a level of 17.5+0.5 gmol/g dry wt. Despite this reduced ATP content at 0 minutes of ischemia, ATP content after 10 minutes of continuous ischemia was significantly higher in the preconditioned animals (12.4±0.5 [preconditioned] vs. 9.1 ± 0.8 [control] gmol/g dry wt, p< 0.01). However, ATP contents were not significantly different between control and preconditioned groups after 20 or 40 minutes of sustained ischemia. Hence, the early phase of ATP depletion was significantly slower in preconditioned hearts.
Adenine nucleotide content (ATP+ADP+AMP) is presented in Table 2 . Preconditioned hearts had a significantly reduced adenine nucleotide pool at 0 minutes of ischemia (20.4+0.4 [preconditioned] vs. 29.2 + 0.3 [control] gmol/g dry wt, p< 0.01). However, by 10 minutes of sustained ischemia, adenine nucleotide content was significantly higher in precondi- FIGURE 5 . Photomicrograph ofpreconditioned myocardium before the onset ofsustained ischemia (i.e., after the fourth 5-minute reperfusion). In general, the structure is indistinguishable from nonischemic tissue ( Figure 2 ). The myofibrils are slightly contracted, and nuclear (Nu) chromatin is finely dispersed. Glycogen granules are present within the sarcoplasm. Mitochondria (M) have tightly packed cristae and electron-dense matrices. An intercalated disk (ID) is present and appears normaL Occasional lipid droplets (LD) are present among mitochondria, a finding also common to nonischemic myocardium. T, triad (T tubule with sarcoplasmic reticulum on either side). Collateral blood flow in this heart was 0. 02 ml/min . g. The bar denotes 1 pnm. Original magnification, x8,800. tioned hearts (19.7 ±0.4 [preconditioned] vs. 16 .6±0. 9 [control] gmol/g dry wi, p<0.01). Thus, as with ATP, preconditioning caused a slowing in the initial rate of adenine nucleotide degradation. However, after 20 and 40 minutes of sustained ischemia, adenine nucleotide content was not significantly different between groups.
Adenine nucleosides (adenosine+inosine) and bases (hypoxanthine+xanthine) are presented in Table 2 . The sum of nucleosides and bases was scant at 0 minutes of ischemia in both groups. In control hearts, there was a progressive accumulation of nucleosides and bases, with the total reaching a level of 16.7±0.9 gumol/g dry wt after 40 minutes. Nucleoside plus base content increased more slowly in preconditioned hearts, due to the slower rate of adenine nucleotide degradation, and did not achieve as high a level after 40 minutes of sustained ischemia (10.1+0.7 gmol/g dry wt). Much less adenosine and inosine were present in preconditioned myocardium during the first 20 minutes of ischemia. However, after 40 minutes of sustained ischemia, the difference of nucleoside plus base content between the two groups could be accounted for entirely by the difference in inosinb content (6.8+0.5 [preconditioned] vs. 13 .1+0.7 [control] gmol/g dry wt). The contents of adenosine, hypoxanthine, and xanthine were nearly identical in the two groups at this time ( Table 2) .
Glycolytic Metabolites and Glycogen Utilization
The time course of lactate accumulation in the two groups is illustrated in Figure 9 . Lactate accumulation was virtually identical in the two groups after 5 minutes. This progressive rise in G-6-P is consistent with glycolytic inhibition at glyceraldehyde-3phosphate dehydrogenase and/or phosphofructokinase. [12] [13] [14] In contrast, preconditioned hearts exhibited a relatively modest increase in G-6-P content, from 0.5+0.1 to 1.6±0.6 ,umol/g dry wt at 20 minutes.
Because of the marked differences in lactate and G-6-P accumulation, it became apparent during the course of the experiment that it was important to know the relative rates of glycogen utilization in preconditioned and control myocardium during ischemia. Unfortunately, in many groups there was insufficient tissue remaining to permit direct measurement of glycogen content. Nevertheless, myocardial glycogen content was measured directly in five dogs in the preconditioned 0-minute group. In nonischemic myocardium, glycogen content was 211±7 ,umol glucose eq/g dry wt. After preconditioning, glycogen content was reduced to 116±+9 ,umol/g dry wt (p<0.01 vs. nonischemic). Thus, preconditioning resulted in depletion of nearly 50% of myocardial glycogen reserves.
To circumvent the absence of direct measurements of glycogen content, we chose to estimate glycogen utilization indirectly by measuring the quantities of key glycolytic intermediates. Separate studies of total ischemia in vitro revealed that, in addition to lactate and G-6-P, significant quantities of glucose, G-1-P, and a-GP accumulated (authors' unpublished observations). Because these latter three metabolites were not measured in most of the original analyses, the available frozen tissue extracts were reanalyzed. Lac-tate content was measured again to ensure that the extracts had not dehydrated during storage. Furthermore, these metabolites were measured in several fresh extracts obtained from freeze-dried tissue samples remaining from the control 20-minute and control 40-minute groups. In all cases, the stored extracts were within the range defined by the fresh extracts. Thus, we concluded that metabolite levels in the stored extracts were accurate.
Glycogen utilization was estimated according to the equation: glycogen utilization= [0.5 x (Alactate)] + [0.5 x (Aa-GP)] +AG-1-P+ AG-6-P+A&glucose.
This equation was validated in a model of total ischemia in which there is no collateral blood flow and, thus, no possibility for washout of metabolites. When globally ischemic dog myocardium was used in vitro, glycogen utilization was determined by direct measurement and compared with utilization estimated by the changes in glycolytic intermediates. Results of these pilot studies showed that the indirect calculation provided a good estimate of glycogen utilization through the entire reversible phase of ischemic injury (up to 60 minutes in vitro). When injury entered the irreversible phase (90 minutes or greater in vitro), the indirect method underestimated utilization, perhaps due to dephosphorylation of some of the intermediates (data not shown).
Further studies were done on severely ischemic myocardium in vivo to evaluate the validity of this technique. Direct and indirect glycogen utilization were compared in 11 dogs from this study subjected to 10, 20, or 40 minutes of permanent ischemia. In this analysis, the indirect estimate averaged 83% of directly measured glycogen utilization, with a correlation coefficient of 0.86. This modest underestimation was likely due to washout of small amounts of lactate by collateral flow. From these studies, we concluded that the indirect calculation provides a reasonable estimate of the relative rates of glycogen utilization.
Myocardial contents of glucose, G-1-P, and a-GP are given in Figure 10 . Glucose content (Figure lOA ) in nonischemic myocardium averaged 1.2±0.2 ,umol/ g dry wt. This increased gradually to 8.2±0.7 gmol/g dry wt by 20 minutes. The reason for this increase in glucose is not clear but may be due to dephosphorylation of G-1-P and G-6-P. In the preconditioned 0-minute group, the initial level of glucose was much higher, averaging 9.8 ± 1.2 ,umol/g dry wt. This increase is likely due to expansion of the extracellular space by reactive hyperemia, as well as enhanced cellular uptake. Since tissue glucose levels decreased to 1.4 ±0.3 ,umol/g dry wt after 5 minutes of ischemia, it is clear that this extra glucose was metabolized.
G-1-P content (Figure lOB) was low in preconditioned and control myocardium at the onset of ischemia (0.2±0.1 and 0.4±0.1 gmol/g dry wt, respectively). In control hearts, G-1-P content increased steadily to 3.1±0.4 ,gmol/g dry wt by 20 minutes. In preconditioned hearts, G-1-P content increased mod- . Photomicrograph ofpreconditioned myocardium after 40 minutes of sustained ischemia. Injury in this group was also heterogeneous. Hearts with only moderate ischemia had many regions with mild reversible injury, similar to Figure  6A . In hearts with severe ischemia, there was both severe reversible injury and irreversible injury. Myocardial a-GP levels are given in Figure lOD Minutes of Sustoined Ischemia FIGURE 8. Graph showing subendocardialATP depletion in severely ischemic control and preconditioned hearts. In control hearts, ATP depletion was rapid for the initial 10 minutes of ischemia and slowed thereafter, reaching 11% of control content by 40 minutes. Preconditioned hearts began the sustained occlusion with less ATP. However, because ATP depletion was substantially slower at the onset of ischemia, by 10 minutes ATP content was higher in preconditioned hearts (p<0.01). ATP content was similar in the control vs. preconditioned groups at 20 and 40 minutes. Data were obtained from all animals with subendothelial collateral flow of 0.07 ml/min * g or less.
tion of dihydroxyacetone phosphate. Formation of a-GP, like conversion of pyruvate to lactate, occurs concomitant with oxidation of NADH to NAD. Increased availability of NAD, in turn, permits increased flux through the glyceraldehyde-3phosphate dehydrogenase reaction, which is ratelimiting during ischemia. Initial levels of a-GP were similar in preconditioned and control tissue (3.5+0.6 and 3.5+0.2 ,umol/g dry wt, respectively). In control myocardium, a-GP increased significantly after 20 minutes of ischemia, reaching 22.0±0.7 ,gmol/g dry wt. In preconditioned myocardium, the increase in a-GP was similar to control for the first 10 minutes of ischemia; however, after 20 minutes of ischemia, these hearts had significantly less a-GP than controls (14.2+2.2 ,umol/g dry wt, p<O.O5). The magnitude of this increase in a-GP in control ischemic myocardium was surprising and had not previously been demonstrated. Estimated glycogen utilization for the first 20 minutes of ischemia is shown in Figure 11 . Glycogen was used at a nearly constant rate in control myocardium, averaging 28.6+0.6 ,umol/g dry wt at 5 minutes, 61.0+2.7 ,umol/g dry wt at 10 minutes, and 110.0+5.9
,umol/g dry wt by 20 minutes. In preconditioned myocardium, glycogen utilization was similar for the first 5 minutes, averaging 24.3+±2.3 ,tmol/g dry wt. However, after 10 minutes, preconditioned myocardium had used only 71% as much glycogen as controls (43.2+2.5 ,umol/g dry wt). After 20 minutes of ischemia, preconditioned myocardium had used only 55% as much glycogen as control myocardium (60.4+±2.9 ,Lmol/g dry 
Minutes of Sustained Ischemia
Minutes of Sustained Ischemio FIGURE 10. Graphs showing glycolytic metabolite levels. Panel A: Glucose. In control myocardium, glucose content increased steadily during the first 20 minutes of ischemia, possibly as a result of dephosphorylation of glucose-i-phosphate and glucose-6-phosphate. In preconditioned myocardium, glucose content was significantly increased at the onset of ischemia and decreased steadily thereafter. Data were obtained from all animals with subendocardial collateral flow of 0.10 mllmin -g or less. Panel B: Glucose-i-phosphate. Glucose-i-phosphate levels were low in both groups at 0 minutes ofischemia. In controls, there was a progressive increase in glucose-i-phosphate during the first 20 minutes of ischemia, most likely due to inhibition ofglycolysis. In preconditioned hearts, there was only a slight increase in glucose-i-phosphate over the same time frame. Data were obtained from all animals with subendocardial collateral flow of 0.10 ml/min *g or less. Panel C: Glucose-6-phosphate. In control hearts, glucose-6-phosphate accumulated rapidly over the first 20 minutes of ischemia. In preconditioned myocardium, glucose-6-phosphate levels rose only modestly durng the first 10 minutes and were not further increased at later time points. Glucose-6-phosphate content in preconditioned myocardium was significantly lower than control myocardium after 10 minutes (p<O.OOS) and 20 minutes (p<0.005) ofischemia. Data were obtainedfrom all animals with subendocardial collateralflow of0.07 ml/min g or less. Panel D: a-Glycerophosphate. a-Glycerophosphate levels were low in both groups at 0 minutes of ischemia. In controls, there was a progressive increase in ac-glycerophosphate content during the first 20 minutes of ischemia. In preconditioned hearts, ai-glycerophosphate also increased; after 10 minutes of ischemia, they contained, on average, more ac-glycerophosphate than controls. After 20 minutes ofischemia, a-glycerophosphate contentfell in preconditioned hearts to below the control 20-minute level. Data were obtained from all animals with subendocardial collateral flow of 0.10 ml/min g or less.
wt). Thus, preconditioning resulted in a substantially slower rate of glycogen breakdown.
HEP Utilization
The calculated rate of HEP utilization in control and preconditioned hearts with collateral flow of 0.07 ml/min g or less is illustrated in Figure 12 . The contribution of CP to HEP utilization in control dogs is estimated by using previously published measurements of CP content in nonischemic myocardium.1'516 In preconditioned hearts, the CP content was estimated, assuming an initial "CP overshoot" that is known to occur on reperfusion of reversibly injured myocardium.17-19 During the initial 5 minutes of ischemia, the calculated rate of HEP utilization was 23.8 ,mol/min g dry wt in control hearts versus 24.8 gmol/min g dry wt in preconditioned hearts. However, in preconditioned hearts, HEP utilization was roughly half that calculated for controls between 5 and 10 minutes (16.6 [control] vs. 7.7 [preconditioned] ,mol/min g dry wt) and between 10 and 20 minutes (11.6 [control] vs. 6.4 [preconditioned] gmol/ min g dry wt). HEP utilization was similarly slow in preconditioned and control hearts over the terminal 20 minutes of ischemia (2.3 vs. 2.2 ,mol/min * g dry wt, respectively).
Discussion We observed previously that preconditioning dramatically limited myocardial infarct size after 40 Graph showing estimated glycogen utilization in severely ischemic control and preconditioned hearts. Glycogen utilization was calculatedfrom changes in myocardial glucose, glucose-i-phosphate, glucose-6-phosphate, a-glycerophosphate, and lactate, as descrbed in the text. In control myocardium, glycogen was used at a nearly constant rate for the first 20 minutes of ischemia. In preconditioned myocardium, glycogen utilization was less at all times. See text for further information. Data were obtainedfrom all animals with subendocardial collateral flow of 0.10 ml/min * g or less.
minutes of sustained ischemia and 4 days of reperfusion.1 Thus, preconditioning delays the onset of irreversible cell injury. The ultrastructural observations of the present study are consistent with the previously reported histological results, in that preconditioned hearts developed ultrastructural injury more slowly than control hearts. For example, after 20 minutes of ischemia, preconditioned myocardium had less cell swelling, reduced myofibrillar stretching, and enhanced preservation of nuclear and mitochondrial structure. Control hearts began to exhibit mitochondrial amorphous matrix densities, signs of irreversible ischemic injury, by 20 minutes; none were observed in the 20-minute preconditioned group. By 40 minutes, structural signs of irreversible injury (i.e., mitochondrial amorphous matrix densities and sarcolemmal breaks) were widespread in control hearts, but in preconditioned hearts, irreversible injury was still focal. Although the aforementioned ultrastructural features of ischemic injury developed more slowly in preconditioned myocardium, when injury did occur, it was qualitatively similar in both groups. Biochemical analyses in the present study revealed that energy metabolism during ischemia was slowed markedly by preconditioning, resulting in reduced accumulation of metabolic products and temporary preservation of ATP stores. Our working hypothesis to explain the effects of preconditioning on metabolism and viability is shown in Figure 13 . We propose that preconditioning reduces the metabolic requirements of ischemic myocardium. A reduced metabolic demand slows the rate of HEP utilization; this, in Bar graph showing subendocardial high energy phosphate (HEP) utilization in severely ischemic control (CON) and preconditioned (PRE) hearts. CON tissue was estimated to have a creatine phosphate (CP) content of 40 pmol/g dry wt. PRE myocardium was assumed to have a CP content of60 pimol/g dry wt. CP was assumed to be completely hydrolyzed within the first 5 minutes of ischemia in both groups. HEP utilization during the first 5 minutes of ischemia was approximately equal in the two groups. The rate of HEP utilization in PRE hearts was 46% of the CON rate between 5 and 10 minutes ofischemia and 55% ofthe CON rate between 10 and 20 minutes. HEP utilization was similarly slow in the two groups in the terminal 20 minutes of ischemia. Calculations are based on the most severely ischemic subgroup of dogs, with subendocardial collateral flows of 0.07 mllmin g.
AN, HEP depletion from breakdown of adenine nucleotides;
AG, HEP production from anaerobic glycolysis.
turn, results in preservation of ATP stores and a reduced rate of anaerobic glycolysis. Reduced rates of glycolysis and HEP depletion, consequently, lead to limitation of catabolite accumulation. Either pres--ervation of ATP or limitation of catabolite accumulation (or both) may be responsible for increased cellular viability. This hypothesis, that preconditioning is protective because it reduces the energy demand during ischemia, appears to be the only logical explanation for slower metabolic activity in the setting of preserved energy stores and enhanced cellular viability. For example, if the glycolytic rate were limited by glycogen depletion, we would expect that ATP depletion would have occurred more rapidly in preconditioned myocardium. Furthermore, if preservation of ATP content resulted from impaired ability to use existing ATP stores, we would have expected cell death to have occurred more quickly due to absence of critical ATP-dependent reactions. In the following sections, we shall discuss in more specific terms how these metabolic changes may have occurred and how they may interact to preserve cellular viability.
Reduced Rate of HEP Utilization
Preconditioned hearts lost ATP much more slowly than controls for the first 20 minutes of sustained FIGURE 13 . Diagram showing hypothesis for mechanism of myocardial protection by preconditioning. We propose that preconditioning reduces myocardial energy demand durting ischemia, resulting in a decreased rate of high energy phosphate (HEP) utilization. A reduced rate ofHEP utilization, in turn, results in preservation ofA TP stores and a reduced rate of anaerobic glycolysis. Reduced rates of glycolysis and HEP depletion, consequently, cause limitation of catabolite accumulation. Either preservation ofATP content or limitation of catabolite accumulation (or both) may be responsible for slowing the rate of ischemic cell death.
ischemia (Figure 8 ). Theoretically, this slowed ATP depletion could be the result of decreased ATP utilization or increased ATP production. Increased ATP production from aerobic metabolism is unlikely, however, since collateral blood flows were not different among groups (Table 3 ). Increased ATP production from anaerobic glycolysis also is not possible; lactate accumulation was virtually identical during the first 5 minutes of ischemia and thereafter was substantially slower in preconditioned hearts. A CP overshoot could provide a temporary source of HEP for additional ATP production. However, CP is hydrolyzed rapidly after the onset of ischemia,1920 and consequently, a CP overshoot is unlikely to contribute to preservation of ATP content beyond 5 minutes of sustained ischemia. On the other hand, we have provided evidence that preconditioning slows the rate of HEP utilization. Although the calculated rates of HEP utilization were nearly equal in the two groups during the first 5 minutes of ischemia, HEP utilization was substantially slower in preconditioned hearts between 5 and 20 minutes of sustained ischemia (Figure 12 ). Thus, the slower ATP depletion in preconditioned hearts most likely was due to a reduced rate of HEP utilization.
The reason for a reduced rate of ATP hydrolysis after repetitive episodes of ischemia is unknown. Unfortunately, little is known about the reactions that consume ATP during ischemia in control myocardium. These include various transport ATPases of the sarcolemma or sarcoplasmic reticulum, mitochondrial ATPases, and some other relatively minor ATP-using reactions that can occur under ischemic conditions.2' One potential reaction that might be affected by preconditioning is the activity of the myosin ATPase. For example, preconditioning could hasten the rate at which contractile failure develops during ischemia (for a detailed review of the meta-bolic aspects of contractile failure, see Allen and Orchard22). Another possibility is that preconditioned hearts begin the sustained occlusion at a lower level of contractile activity, as a result of postischemic "stunning."23,24 Either or both of these processes could slow the early rate of ATP utilization and, hence, depletion. Hoffmeister et al19 reported that multiple 3-minute coronary occlusions reduced the rate of ATP depletion during ischemia and also attributed this effect to reduced contractile activity.
Accumulation of adenine nucleosides and bases (Table 2) was much slower over the first 10 minutes of ischemia, reflecting the slower adenine nucleotide degradation. Although the rate of nucleotide degradation in preconditioned hearts increased between 10 and 40 minutes, the final content of nucleosides and bases was still lower in preconditioned than in control hearts. Comparison of the sum of adenine nucleotides, nucleosides, and bases between 0 minutes and 40 minutes provides an estimate of nucleoside and base washout by collateral flow. The small amount of nucleosides and bases not recovered was similar in preconditioned and control hearts. Hence, the reduced nucleoside plus base content at the end of 40 minutes of ischemia is most likely explained by reduced availability of AMP for further catabolism in preconditioned hearts. AMP is produced by adenylate kinase, which captures the HEP of ADP, forming ATP and AMP. Thus, the reduced rate of ATP depletion slowed ADP production and consequently slowed formation of AMP.
Reduced Rate ofAnaerobic Glycolysis
Preconditioning substantially slowed the accumulation of several glycolytic metabolites measured during the ensuing 40 minutes of ischemia. Production of lactate was similar in both groups for the first 5 minutes of ischemia (Figure 9 ). Between 5 and 20 minutes, however, lactate accumulation was much slower in preconditioned hearts. Furthermore, the final extent of lactate accumulation was less. This indicates that the glycolytic rate was substantially slower in preconditioned hearts. The explanation for the reduced rate of anaerobic glycolysis in preconditioned myocardium could be either 1) tight coupling of the rate of glycolysis to the rate of HEP utilization, which was reduced in preconditioned myocardium, or 2) limited availability of substrates for anaerobic glycolysis due to reduced glycogenolysis. These possibilities will be discussed below.
Previous studies from this laboratoryl1025 have shown a very tight pairing between the rate of ATP depletion and lactate accumulation. Although it is not known precisely how the rate of ATP breakdown influences lactate production, it is clear that reductions in demand for ATP (e.g., by hypothermia) slow the rates of ATP depletion and anaerobic glycolysis in parallel; conversely, increases in demand for ATP (e.g., by hyperthermia or electrical pacing) hasten the rates of ATP depletion and anaerobic glycolysis. 25 In any case, ATP formation via anaerobic glycolysis never is sufficient to prevent ATP depletion. Thus, the slower ATP depletion in preconditioned hearts would be expected to drive anaerobic glycolysis at a slower rate and to result in less accumulation of glycolytic intermediates.
The alternate hypothesis is that a reduced rate of glycogenolysis slowed glycolysis by limiting substrate availability. Based on our estimations (Figure 11 ), glycogen breakdown occurred more slowly in preconditioned hearts. However, we do not believe that slower glycogenolysis limited the rate of glycolysis for the following reason: In severe ischemia, anaerobic glycolysis is absolutely required to maintain ATP levels. For example, if glycolysis is inhibited through iodoacetate poisoning, myocardial ATP levels fall to virtually zero within a few minutes of ischemia. 26 Thus, if glycolysis were limited by substrate availability, ATP depletion should have been accelerated in preconditioned hearts; this is inconsistent with our observation of slowed ATP depletion.
Why, then, is glycogen breakdown slower in preconditioned myocardium? One possibility is that partial depletion of glycogen by preconditioning limited the subsequent rate of glycogenolysis. However, as discussed above, substrate depletion is inconsistent with preservation of myocardial ATP content. Rather, we propose that glycogen breakdown was slower due to a reduced activity of phosphorylase, the rate-limiting enzyme for glycogenolysis. The activity of this enzyme is linked to energy demand through allosteric regulation, in that it is activated by AMP and inhibited by ATP. The higher ATP/AMP ratio in preconditioned hearts would favor inhibition of phosphorylase b; however, lower G-6-P levels would favor less inhibition, tending to offset the former effect. Additionally, the ratio of phosphorylase a/b might be lower in preconditioned hearts if, for example, preconditioning reduced adrenergic stimulation during ischemia.
Thus, although our results indicate that glycogenolysis was reduced in parallel with the reduced rate of anaerobic glycolysis, the data also suggest that, in the time frame of the present study, the slower rate of anaerobic glycolysis most likely was not due to lack of glycogen or inhibition of glycogenolysis. Rather, we propose that anaerobic glycolysis was slowed because the demand for HEP production was reduced.
Myocardial Protection by Preconditioning
The development of lethal ischemic injury has been closely linked to severe ATP depletion.5,27 It is quite possible that preservation of cellular ATP stores is responsible for slowing the rate of cell death in preconditioned hearts. Although hearts of both groups exhibited similar ATP content at the end of the 40-minute occlusion, the myocardium of preconditioned animals spent substantially less time with critically low ATP levels. If this preservation of ATP content is responsible for protection, it implies one of two options: either the metabolic work required to sustain viability has been reduced (e.g., reduced transmembrane ion leakage) or consumption of ATP in preconditioned myocardium has been redirected. In the latter case, the activity of some "nonessential" pathway that consumes significant amounts of ATP in control hearts would be reduced, making ATP available for other reactions critical to cellular homeostasis. For example, ATP could be shunted from ineffectual contractile efforts to maintenance of ionic gradients or biosynthesis.
It is possible that reduced accumulation of glycolytic intermediates (such as lactate, H+, and NADH) was responsible for the protective effect of preconditioning. Lactate accumulation has been reported to cause marked alterations in mitochondrial structure. 28 An interesting study by Neely and Grot-yohann29 examined the relation between accumulation of glycolytic products and recovery of mechanical function after ischemia. Isolated rat hearts were depleted of glycogen by anoxic perfusion and then subjected to global ischemia. Although ATP contents in these hearts were similar to hearts that were only made ischemic, lactate content was substantially reduced in the anoxically preperfused group. These hearts exhibited a much better functional recovery than hearts that were only made ischemic. Furthermore, the enhanced recovery of function was abolished when lactate was added to the anoxic preperfusion buffer. They concluded that accumulation of glycolytic intermediates (lactate, H+, and NADH) and not ATP depletion limited recovery of mechanical function. However, they made no observations regarding cellular viability.
Although we did not measure myocardial pH in this study, it is likely that the preconditioning resulted in less severe acidosis during ischemia. For example, Fleet et a130 studied changes in extracellular pH during multiple ischemic episodes and reported a progressive diminution in myocardial acidosis. This may result, at least in part, from reduced lactate accumulation. Garlick et a131 have demonstrated that glycogen-depleted hearts developed less acidosis during ischemia. Additionally, slower ATP breakdown and a reduced adenine nucleotide pool dictate that fewer protons will be generated by hydrolysis of adenine nucleotide HEP bonds.32 Furthermore, hydrolysis of CP consumes protons in approximately a 1:1 ratio.32 A CP overshoot would thereby provide a "proton sink" for subsequent episodes of ischemia. Myocardial acidosis has been shown to cause severe chromatin clumping and contribute to formation of mitochondrial amorphous matrix densities.33 These structural alterations were notably reduced by preconditioning in our present study. Alternatively, or additionally, reduced intracellular acidosis could limit Ca2' accumulation during reperfusion, which has been proposed to occur via sequential H+/Na+ and Na+/Ca2' exchange.34
Theoretically, a reduced adenine nucleotide pool could lead to reduced hypoxanthine and xanthine production during ischemia, which in turn might limit free radical production on reperfusion via the xanthine oxidase pathway. 35 However, there was no significant difference in hypoxanthine or xanthine contents after 40 minutes of sustained ischemia in the control versus preconditioned groups ( Table 2) . Furthermore, we have been unable to demonstrate infarct size limitation by inhibition of xanthine oxidase with allopurinol36 or oxypurinol37 in the same experimental model. Thus, elimination of xanthine oxidase-derived free radicals cannot explain the effect of preconditioning.
The summed effect of ischemic catabolites is to act as an osmotic load on the cell. This osmotic load may contribute to lethal injury by causing swelling of cells with damaged sarcolemmas or cytoskeletal membrane supports. [38] [39] [40] If so, then preconditioning may be protective by preventing osmotically induced rupture of cell membranes. This hypothesis is supported by our electron microscopic observation that cell swelling was significantly reduced, on the average, in preconditioned hearts.
Conclusions
Myocardium preconditioned with brief episodes of ischemia and reperfusion develops structural signs of lethal ischemic injury more slowly than control myocardium. The results of the present study suggest that this preservation of cellular structure is due to reduced myocardial energy demand during ischemia. Although initial ATP levels are lower in preconditioned hearts, a slowed rate of ATP utilization results in temporary preservation of HEP content. This reduced HEP utilization may be due to lower metabolic requirements for contractile activity of postischemic "stunned" myocardium or to inhibition of other ATPases that "squander" energy during ischemia. Glycogenolysis and anaerobic glycolysis are much slower in preconditioned hearts; slowing of these processes most likely reflects the reduced requirements for glycolytically produced ATP. The reduced rates of glycogenolysis and glycolysis result in reduced accumulation of G-1-P, G-6-P, and lactate. Accumulation of purine nucleosides and bases also is reduced markedly in preconditioned hearts. Either preservation of ATP stores or reduced catabolite accumulation (or both) may be the mechanism by which a reduced energy demand maintains cell viability in the preconditioned heart during ischemia.
